Media Center
- No
-
Category
- Show all
- Press Release
- News Article
- PR Video
- CEO Story
- Title
- Author
- Time uploaded
- Views
- Likes
- 14
- Press Release
- Press Release PharmAbcine Unveils Olinvacimab’s Positive Results from Phase Ib Combination Studies at KSMO 2020
- 관리자
- 15 Sep 2020
- Views2310
- 0
- 13
- Press Release
- Press Release PharmAbcine signs a CMO contract with Binex so Binex can produce olinvacimab at its new 5,000L production line
- 관리자
- 3 Sep 2020
- Views1765
- 0
- 12
- Press Release
- Press Release PharmAbcine is presenting at the KSMO 2020
- 관리자
- 3 Sep 2020
- Views1551
- 0
- 11
- Press Release
- Press Release PharmAbcine signs a research collaboration agreement with Wuxi Shuangliang Biotechnology (SLBio) to evaluate a combination therapy to treat NSCLC
- 관리자
- 20 Aug 2020
- Views1362
- 0
- 10
- Press Release
- Press Release PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA)...
- 관리자
- 20 Aug 2020
- Views1463
- 0
- 9
- Press Release
- Press Release PharmAbcine to Present Preclinical Data of Blood Vessel Stabilizing PMC-402 at 2020 AACR Meeting
- 관리자
- 20 May 2020
- Views1734
- 0
- 8
- Press Release
- Press Release Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment
- 관리자
- 7 Apr 2020
- Views1711
- 0
- 7
- Press Release
- Press Release PharmAbcine, Announces Acceptance of Phase Ib Olinvacimab and Pembrolizuamb Combination Trial in rGBM Patients Abstract at the 2020 ASCO Annual Meeting
- 관리자
- 6 Apr 2020
- Views1895
- 0
- 6
- Press Release
- Press Release PharmAbcine, Olinvacimb, able to manage the first recruitment of patients for phase II clinical trial
- 관리자
- 20 Nov 2019
- Views2108
- 0
- 5
- Press Release
- Press Release PharmAbcine,BioPharma Dealmakers_sep 2019
- 관리자
- 1 Oct 2019
- Views1902
- 0